KLOW – GHK-Cu 50mg, BPC-157 10mg, TB-500 (TB4) 10mg, KPV 10mg (80mg Blend)

$109.99

  • GHK-Cu: 50mg
  • BPC-157: 10mg
  • TB-500 (TB4): 10mg
  • KPV: 10mg
  • Total Listed Material: 80mg
  • Appearance: Blue to purplish-blue lyophilized powder
  • Vial Size: 5mL
  • Intended Use: Controlled laboratory research only

50 in stock

SKU: LPKLO80 Categories: , Tags: , ,
Description

KLOW Peptide – GHK-Cu / BPC-157 / TB-500 / KPV Advanced Research Blend

KLOW is a multi-component peptide research blend containing GHK-Cu 50mg, BPC-157 10mg, TB-500 (TB4) 10mg, and KPV 10mg. The four listed quantities provide a combined total of 80mg of research material in a 5mL vial.

The supplied material is described as a blue to purplish-blue lyophilized powder. Each component has its own sequence, molecular formula, molecular weight, PubChem identifier, and CAS number and should therefore be evaluated independently when reviewing scientific literature.

KLOW Peptide Research Blend Overview

The KLOW peptide formulation combines four separately specified research materials:

Component Amount Molecular Weight CAS Number
GHK-Cu 50mg 340.384 g/mol 89030-95-5
BPC-157 10mg 1419.556 g/mol 137525-51-0
TB-500 (TB4) 10mg 4963 g/mol 77591-33-4
KPV 10mg 342.43 g/mol 67727-97-3

Because this is a multi-component formulation, the complete blend should not be assigned one molecular formula or molecular weight. Each constituent retains its own supplied molecular characteristics.

GHK-Cu 50mg Specifications

GHK-Cu represents the largest listed component of the KLOW formulation at 50mg.

Sequence: Gly-His-Lys
Molecular Formula: C14H23CuN6O4
Molecular Weight: 340.384 g/mol
PubChem CID: 73587
CAS Number: 89030-95-5

Researchers can explore the supplied formula using the PubChem GHK-Cu molecular formula search.

The supplied sequence and identifiers can support laboratory documentation and comparison with appropriately matched scientific resources.

BPC-157 10mg Specifications

The second listed component is BPC-157 at 10mg.

Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Molecular Formula: C62H98N16O22
Molecular Weight: 1419.556 g/mol
PubChem CID: 9941957
CAS Number: 137525-51-0

The supplied molecular formula can be explored through the PubChem BPC-157 formula search.

These molecular specifications should be considered when matching the material with database records or research literature.

TB-500 10mg Research Component

TB-500 (TB4) is supplied at 10mg within the blend.

The provided sequence is:

Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser-OH

Additional supplied specifications include:

Molecular Formula: C212H350N56O78S
Molecular Weight: 4963 g/mol
PubChem CID: 16132341
CAS Number: 77591-33-4

Researchers can examine the supplied molecular formula through the PubChem TB-500 formula search.

The alternative search spelling tb500 may also be encountered when locating information about this component.

KPV 10mg Specifications

KPV is supplied at 10mg within the KLOW peptide research blend.

The provided sequence is:

Lys-Pro-Val

Additional supplied specifications include:

Molecular Formula: C16H30N4O4
Molecular Weight: 342.43 g/mol
PubChem CID: 125672
CAS Number: 67727-97-3

PubChem note: The supplied KPV information identifies CID 125672, while the attached link points to compound 73587. Because these references conflict, researchers should independently verify the database record before using that link as molecular confirmation.

KLOW Peptides and Multi-Component Research

The search variation klow peptides may be used when looking for information about this multi-component formulation.

The blend combines materials with distinct molecular characteristics. Researchers should therefore avoid assuming that evidence concerning one isolated component automatically describes the complete formulation.

For example, literature concerning GHK-Cu alone does not establish the same experimental result for a combination containing GHK-Cu, BPC-157, TB4, and KPV.

Research involving combinations requires experimental designs capable of distinguishing observations associated with the complete formulation from those previously reported for individual components.

KLOW Peptide Dose – Research Context

The phrase klow peptide dose reflects search interest concerning quantities and administration.

This product page does not provide a human dose, injection quantity, self-administration schedule, or treatment protocol.

The supplied product information instead describes the material composition:

  • 50mg GHK-Cu
  • 10mg BPC-157
  • 10mg TB4
  • 10mg KPV
  • 80mg total listed material

These quantities identify the composition of the research vial. They should not be interpreted as recommended administration amounts.

Laboratory concentrations should be established according to the experimental model and independently validated research methodology.

KLOW Dosing – Laboratory Research Information

Searches for klow dosing may similarly reflect interest in determining how much of the material should be used.

No human dosing guidance is provided.

Within controlled laboratory investigation, researchers should instead define experimental concentration, sample volume, exposure conditions, controls, and analytical endpoints according to their study design.

The appropriate experimental conditions cannot be determined solely from the amount of material contained in the vial.

KLOW Research and Molecular Documentation

Accurate documentation is particularly important for a multi-component KLOW formulation.

Laboratory records may include:

  • Identity of all four components
  • Quantity of each component
  • Individual sequences
  • Molecular formulas
  • Molecular weights
  • PubChem identifiers
  • CAS numbers
  • Vial size
  • Physical appearance
  • Experimental concentration
  • Research model
  • Analytical methodology
  • Experimental endpoints

Documenting the individual components helps distinguish the complete blend from research involving only one constituent.

Appearance and 5mL Vial Format

The supplied research material is described as a blue to purplish-blue lyophilized powder.

The formulation is supplied in a 5mL vial.

These physical characteristics provide additional product-identification information for inventory and laboratory documentation.

Neither vial capacity nor the total listed material quantity establishes an experimental concentration or personal-use amount.

Laboratory Research Considerations

Controlled investigation involving this KLOW peptide blend should use appropriately defined methodology and experimental controls.

Relevant considerations include:

  • Identity of each component
  • Experimental concentration
  • Research model selection
  • Appropriate controls
  • Sample preparation
  • Exposure conditions
  • Analytical methodology
  • Experimental endpoints
  • Multi-component interactions
  • Reproducibility
  • Data interpretation

Researchers should distinguish evidence involving individual components from evidence involving combinations.

In-vitro, animal, and human studies also represent different evidence settings and should not automatically be treated as interchangeable.

Related OROS Research Materials

Researchers exploring additional laboratory materials can review VIP 10mg as a separately specified research product.

Another catalog option is 5-Amino-1MQ 50mg, which should be evaluated according to its own molecular characteristics.

Researchers interested in another multi-component format can explore AEGIS – BPC-157 / TB-500 / KPV.

These products are provided for research-catalog navigation and should not be interpreted as chemically or experimentally interchangeable.

Scientific Research Resources

Researchers can use PubChem to investigate available chemical records, molecular identifiers, and database information for the individual components.

Peer-reviewed biomedical and experimental literature can be searched through PubMed.

When reviewing scientific publications, researchers should verify the exact compound or combination investigated and consider the study model, methodology, controls, endpoints, and limitations.

KLOW Peptide Research FAQ

What is KLOW peptide?

It is a multi-component research blend containing GHK-Cu 50mg, BPC-157 10mg, TB-500 (TB4) 10mg, and KPV 10mg.

How much total material is listed?

The four supplied component quantities total 80mg.

What is the appearance of the material?

It is described as a blue to purplish-blue lyophilized powder.

What size vial is supplied?

The blend is supplied in a 5mL vial.

Does KLOW contain TB-500?

Yes. The supplied formulation contains TB-500 (TB4) 10mg.

What is the largest component by listed quantity?

GHK-Cu is the largest listed component at 50mg.

Does the 80mg total represent a recommended dose?

No. It represents the combined quantity of the four listed research components and is not a recommended human dose or administration amount.

Is KLOW intended for personal use?

No. This formulation is supplied exclusively for controlled laboratory investigation and is not intended for human or animal consumption, injection, therapeutic application, self-administration, clinical use, bodybuilding, or veterinary application.

Research Use Disclaimer

This KLOW multi-component material is supplied exclusively for controlled laboratory investigation, analytical evaluation, and applicable in-vitro research. It is not intended for human or animal consumption, injection, therapeutic application, diagnosis, clinical use, self-administration, bodybuilding, performance enhancement, or veterinary application. Experimental work should be performed by qualified personnel using appropriately validated laboratory procedures.

Additional information
Net Weight

80mg

Brand

OROS Research

Format

Lyophilized Vial

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “KLOW – GHK-Cu 50mg, BPC-157 10mg, TB-500 (TB4) 10mg, KPV 10mg (80mg Blend)”

Your email address will not be published. Required fields are marked *